Beta-blOckers discoNtinuation in Patients Presenting Heart FaIlure With REcovered Left Ventricular Ejection Fraction

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1300 participants.

Also called NCT06518694

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose other
Phase
Phase 3
Enrolled
  • 1,300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06518694
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06518694. Randomized; single masking; primary purpose other. Start 2025-02-11 (actual); primary completion 2027-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Beta-blOckers discoNtinuation in Patients Presenting Heart FaIlure With REcovered Left Ventricular Ejection Fraction
Acronym
BONFIRE
Condition
Heart Failure
Intervention (Drug)
Βeta-Blockers discontinued (with tapering)
Lead sponsor
Assistance Publique - Hôpitaux de Paris (class: other)

Record details

Record id
cardio:ct-nct06518694
Content hash
421ee8e4dca4db295de9ab12c7b11ecfb30e065410784849e7b935fa2d5f7442